<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>医学新闻</title><description>来自 News-Medical.Net - 来自世界各地的最新医学新闻和研究</description><link/>https://www.news-medical.net/<language> en-GB</language><item><title>研究人员发现与肌肉衰老和肌肉减少症相关的基因</title><description>科学家们发现了以前未报道的基因，它们似乎在肌肉衰老过程中发挥着关键作用。</description><link/> https://www.news-medical.net/news/20241026/Researchers-identify-genes-linked-to-muscle-aging-and-sarcopenia.aspx<comments> https://www.news-medical.net/news/20241026/Researchers-identify-genes-linked-to-muscle-aging-and-sarcopenia.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=1345269c-1fe2-4af6-91d3-63599bec18fe</guid><pubDate> Sat, 26 Oct 2024 07:57:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2018/7/shutterstock_1028141632_649cad8889c647fc8d0bd83bf7503e08-620x480.jpg" width="620"><media:description><![CDATA[Researchers identify genes linked to muscle aging and sarcopenia]]></media:description></media:content></item><item><title>有氧运动可增强接受化疗的女性的认知功能</title><description>许多接受化疗的女性都会出现短期和长期的记忆、注意力和/或思考能力下降（通常称为“化疗脑”或“脑雾”）的情况。在最近一项针对开始乳腺癌化疗的女性的临床试验中，那些同时开始有氧运动计划的女性自我报告，与接受标准护理的女性相比，认知功能和生活质量有了更大的改善。该研究结果由 Wiley 在线发表在美国癌症协会同行评审期刊《CANCER》上。</description><link/> https://www.news-medical.net/news/20241026/Aerobic-exercise-boosts-cognitive-function-in-women-undergoing-chemotherapy.aspx<comments> https://www.news-medical.net/news/20241026/Aerobic-exercise-boosts-cognitive-function-in-women-undergoing-chemotherapy.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=004b7fed-f88c-4b4a-845b-c923872ade24</guid><pubDate> Sat, 26 Oct 2024 07:53:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Chemo_Vials-620x480.jpg" width="620"><media:description><![CDATA[Aerobic exercise boosts cognitive function in women undergoing chemotherapy]]></media:description></media:content></item><item><title>英国睡眠协会主张废除每年两次的时钟变化</title><description>英国睡眠协会（BSS）主张废除英国每年两次的时钟变化并恢复永久标准时间（格林威治标准时间或GMT）。</description><link/> https://www.news-medical.net/news/20241026/British-Sleep-Society-advocates-abolition-of-the-twice-yearly-clock-changes.aspx<comments> https://www.news-medical.net/news/20241026/British-Sleep-Society-advocates-abolition-of-the-twice-yearly-clock-changes.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=be99b229-5ef7-4d80-bf58-57e8487a39ad</guid><pubDate> Sat, 26 Oct 2024 07:50:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/3/Good_nights_sleep_-_Goodluz_5edf6811462b4d0280b9b9189683dde9-620x480.jpg" width="620"><media:description><![CDATA[British Sleep Society advocates abolition of the twice-yearly clock changes]]></media:description></media:content></item><item><title> Ipsen 的 elafibranor 推荐用于罕见肝病患者</title><description>Ipsen 今天宣布，国家健康与护理卓越研究所 (NICE) 推荐 elafibranor 80 毫克片剂与熊去氧胆酸 (UDCA) 联合用于治疗对 UDCA 反应不足的成人 PBC，或作为单一疗法治疗无法耐受的成人UDCA。这使得 elafibranor 成为近十年来第一个被批准在 NHS 上使用的治疗 PBC 的药物。</description><link/> https://www.news-medical.net/news/20241026/Ipsens-elafibranor-recommended-for-use-in-病人-with-rare-liver-disease.aspx<comments> https://www.news-medical.net/news/20241026/Ipsens-elafibranor-recommended-for-use-in-病人-with-rare-liver-disease.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=fbd14296-28f2-4a18-9bd0-f921c399cf4c</guid><pubDate> Sat, 26 Oct 2024 07:37:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/1/Digital_illustration_of_liver_in_colour_background-Liya_Graphics_0fff2ea2f60c4e71b4991068b748916f-620x480.jpg" width="620"><media:description><![CDATA[Ipsen's elafibranor recommended for use in patients with rare liver disease]]></media:description></media:content></item><item><title> MHRA 批准多纳奈单抗治疗早期阿尔茨海默病</title><description>药品和保健产品监管局 (MHRA) 今天，即 2024 年 10 月 23 日，在对益处和风险进行彻底审查后，批准了药物 donanemab (Kisunla) 用于阿尔茨海默病早期阶段的许可。</description><link/> https://www.news-medical.net/news/20241026/MHRA-greenlights-donanemab-for-early-stage-Alzheimere28099s-disease.aspx<comments> https://www.news-medical.net/news/20241026/MHRA-greenlights-donanemab-for-early-stage-Alzheimere28099s-disease.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=bc5ad0c0-1256-46c1-8574-1cfd1f9d07df</guid><pubDate> Sat, 26 Oct 2024 07:28:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2018/7/The_beta_amyloid_peptid%2c_amyloid_plaques_growing_on_a_neuron._It_consists_of_abo_-_Juan_Gaertner_A1_16fab1588231426bb5fea857e8de9ce0-620x480.jpg" width="620"><media:description><![CDATA[MHRA greenlights donanemab for early stage Alzheimer’s disease]]></media:description></media:content></item><item><title>测试多种胶质母细胞瘤新疗法的开创性试验</title><description>今天（10 月 23 日）宣布的一项开创性研究将为英国胶质母细胞瘤患者（一种侵袭性脑癌）患者试验多种新疗法。</description><link/> https://www.news-medical.net/news/20241026/Pioneering-trial-to-test-multiple-new-treatments-for-glioblastoma.aspx<comments> https://www.news-medical.net/news/20241026/Pioneering-trial-to-test-multiple-new-treatments-for-glioblastoma.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=c23f5373-bee1-4499-afe4-ed9be5d5d487</guid><pubDate> Sat, 26 Oct 2024 07:22:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2018/7/Brain_cancer%2c_3D_illustration_showing_presence_of_tumor_inside_brain_-_Kateryna_Kon_M1_6704c47fefe0477dbe1cd3351402914f-620x480.jpg" width="620"><media:description><![CDATA[Pioneering trial to test multiple new treatments for glioblastoma]]></media:description></media:content></item><item><title>新的研究试验旨在解决中风后的致残状况</title><description>由东安格利亚大学 (UEA) 的学者领导并在英格兰八个主要中风中心进行的一项重大新研究试验将测试一种新疗法对影响约三分之一幸存者的中风后致残病症的疗效得益于国家健康与护理研究所 (NIHR) 与医学研究委员会 (MRC) 之间的合作伙伴关系——功效与机制评估 (EME) 计划提供的 126 万英镑资助。</description><link/> https://www.news-medical.net/news/20241026/New-research-trial-aims-to-address-a-disabling-post-中风-condition.aspx<comments> https://www.news-medical.net/news/20241026/New-research-trial-aims-to-address-a-disabling-post-中风-condition.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=07d738b4-7558-4ea6-a233-f0dc9aa06379</guid><pubDate> Sat, 26 Oct 2024 07:19:00 -0400</pubDate> <media:content expression="full" height="350" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_794150_17299415129646058.jpg" width="720"><media:description><![CDATA[New research trial aims to address a disabling post-stroke condition]]></media:description></media:content></item><item><title>患者索赔热线概述了中风的主要症状以及如何降低风险</title><description>每五分钟，英国就会有人中风，该国有 130 万人中风幸存。这种情况既可能危及生命，也可能改变生活，因此了解中风时要注意什么以及如何采取行动至关重要。</description><link/> https://www.news-medical.net/news/20241026/Patient-Claim-Line-outlines-key-signs-of-中风-and-how-to-reduce-risks.aspx<comments> https://www.news-medical.net/news/20241026/Patient-Claim-Line-outlines-key-signs-of-中风-and-how-to-reduce-risks.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=22dc9f97-f5c8-4817-8e13-e36bafefa009</guid><pubDate> Sat, 26 Oct 2024 07:07:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Stroke-620x480.jpg" width="620"><media:description><![CDATA[Patient Claim Line outlines key signs of stroke and how to reduce risks]]></media:description></media:content></item><item><title>人工智能建模为与气候变化相关的腹泻病爆发提供早期预警</title><description>与气候变化相关的极端天气，例如大规模洪水和长期干旱，常常导致危险的腹泻病爆发，特别是在欠发达国家，腹泻病是幼儿死亡的第三大原因。</description><link/> https://www.news-medical.net/news/20241026/AI-modeling-offers-early-warning-for-diarreal-disease-outbreaks-lated-to-climate-change.aspx<comments> https://www.news-medical.net/news/20241026/AI-modeling-offers-early-warning-for-diarreal-disease-outbreaks-lated-to-climate-change.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=6b481b8c-cf8d-4d9c-8e56-3b64fd69b849</guid><pubDate> Sat, 26 Oct 2024 02:42:36 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2016/3/Children_playing_sunset_-_Zurijeta_8c5bdac77e44431bb1bfec67b9c87208-620x480.jpg" width="620"><media:description><![CDATA[AI modeling offers early warning for diarrheal disease outbreaks related to climate change]]></media:description></media:content></item><item><title> GLP-1 治疗肥胖药物的使用激增与减肥手术的下降同时发生</title><description>麻省总医院布里格姆分校的研究人员及其合作者发现，从 2022 年到 2023 年，使用 GLP-1 药物治疗肥胖症的人数增加了一倍多，而手术率却下降了四分之一。</description><link/> https://www.news-medical.net/news/20241026/Surge-in-GLP-1-drug-use-for-obesity-coincides-with-drop-in-bariatric-surgery.aspx<comments> https://www.news-medical.net/news/20241026/Surge-in-GLP-1-drug-use-for-obesity-coincides-with-drop-in-bariatric-surgery.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=fe1fb9a7-58f0-4d41-be56-1c5fa3ff421b</guid><pubDate> Sat, 26 Oct 2024 02:24:25 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/3/Obesity-Jakub_Cejpek_ead0fb8492f0437f96e9fd842630990c-620x480.jpg" width="620"><media:description><![CDATA[Surge in GLP-1 drug use for obesity coincides with drop in bariatric surgery]]></media:description></media:content></item></channel></rss>